Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIX NASDAQ:BTCY NASDAQ:LYRA NASDAQ:TNON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$4.29+1.4%$7.15$4.16▼$36.75$2.30M-1.32166,781 shs44,171 shsBTCYBiotricity$0.11+4.0%$0.13$0.09▼$0.75$3.03M1.1459,360 shs8,733 shsLYRALyra Therapeutics$0.52$0.64$0.30▼$8.75$923K0.6854,492 shs12 shsTNONTenon Medical$0.20-3.1%$0.49$0.19▼$2.48$2.48M1.366.67 million shs677,675 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical-4.94%-26.43%-45.56%-46.77%-87.25%BTCYBiotricity-6.03%-12.61%-12.25%-53.10%-75.64%LYRALyra Therapeutics0.00%+8.33%-23.53%-30.90%-93.42%TNONTenon Medical+3.77%-2.75%-40.29%-73.11%-80.19%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$4.29+1.4%$7.15$4.16▼$36.75$2.30M-1.32166,781 shs44,171 shsBTCYBiotricity$0.11+4.0%$0.13$0.09▼$0.75$3.03M1.1459,360 shs8,733 shsLYRALyra Therapeutics$0.52$0.64$0.30▼$8.75$923K0.6854,492 shs12 shsTNONTenon Medical$0.20-3.1%$0.49$0.19▼$2.48$2.48M1.366.67 million shs677,675 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical-4.94%-26.43%-45.56%-46.77%-87.25%BTCYBiotricity-6.03%-12.61%-12.25%-53.10%-75.64%LYRALyra Therapeutics0.00%+8.33%-23.53%-30.90%-93.42%TNONTenon Medical+3.77%-2.75%-40.29%-73.11%-80.19%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 2.00Hold$42.00879.02% UpsideBTCYBiotricity 0.00N/AN/AN/ALYRALyra Therapeutics 1.50ReduceN/AN/ATNONTenon Medical 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest LYRA, BTCY, TNON, and AMIX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2026TNONTenon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/10/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)6/23/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)6/3/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)6/2/2026AMIXAutonomix Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/18/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)5/13/2026TNONTenon Medical Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)(Data available from 7/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$10.85 per shareN/ABTCYBiotricity$12.06M0.26N/AN/A($1.30) per share-0.08LYRALyra Therapeutics$600K1.54N/AN/A$8.86 per share0.06TNONTenon Medical$3.94M0.61N/AN/A$0.18 per share1.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$16.72M-$74.58N/AN/AN/AN/A-239.36%-192.46%8/12/2026 (Estimated)BTCYBiotricity-$14.09M-$0.12N/AN/AN/A-80.42%N/A-188.47%7/21/2026 (Estimated)LYRALyra Therapeutics-$93.43M-$19.15N/AN/AN/A-5,491.17%-1,010.91%-58.92%N/ATNONTenon Medical-$12.56M-$1.29N/AN/AN/A-270.09%-907.60%-110.17%8/12/2026 (Estimated)Latest LYRA, BTCY, TNON, and AMIX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2026Q1 2027AMIXAutonomix Medical-$6.4050N/AN/AN/AN/AN/A8/12/2026Q2 2026TNONTenon Medical-$0.24N/AN/AN/A$1.54 millionN/A5/12/2026Q1 2026TNONTenon Medical-$0.3050-$0.31-$0.0050-$0.31$1.30 million$1.38 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/ABTCYBiotricityN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/ATNONTenon MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A4.454.45BTCYBiotricityN/A0.230.10LYRALyra TherapeuticsN/A2.432.43TNONTenon MedicalN/A1.030.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%BTCYBiotricity3.89%LYRALyra Therapeutics95.62%TNONTenon Medical22.74%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical6.20%BTCYBiotricity1.60%LYRALyra Therapeutics3.25%TNONTenon Medical17.71%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical1540,000509,000N/ABTCYBiotricity4028.60 million22.08 millionNo DataLYRALyra Therapeutics501.78 million1.72 millionNo DataTNONTenon Medical811.85 million9.75 millionNot OptionableLYRA, BTCY, TNON, and AMIX HeadlinesRecent News About These CompaniesTenon Medical regains Nasdaq complianceJuly 20 at 6:50 PM | seekingalpha.comTenon Medical Regains Nasdaq Listing Compliance After OfferingJuly 20 at 8:50 AM | tipranks.comTenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity RequirementJuly 20 at 8:00 AM | accessnewswire.comATenon Medical Raises Capital, Regains Nasdaq Equity ComplianceJuly 10, 2026 | tipranks.comTenon Medical Completes $4.2 Million Public OfferingJuly 2, 2026 | tipranks.comTenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion SystemJuly 2, 2026 | accessnewswire.comAWallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public OfferingJuly 1, 2026 | prnewswire.comTenon Medical, Inc. Announces Closing of $4.2 Million Public OfferingJuly 1, 2026 | accessnewswire.comATenon Medical prices $4.2M public offeringJune 30, 2026 | msn.comWallachBeth Capital Announces Pricing of Tenon Medical, Inc. $4.2 Million Public OfferingJune 30, 2026 | prnewswire.comTenon Medical, Inc. Announces Pricing of $4.2 Million Public OfferingJune 30, 2026 | accessnewswire.comATenon Medical (TNON) stock jumps nearly 83% after hours: Here's what is going onJune 19, 2026 | msn.comTenon Medical Extends Executive Chairman Consulting AgreementJune 12, 2026 | tipranks.comTenon Medical Updates Bylaws to Ease Shareholder QuorumJune 11, 2026 | tipranks.comTenon Medical Faces Nasdaq Deficiency, Compliance Plan DueMay 22, 2026 | tipranks.comTenon Medical CEO Foster buys $25k in TNON stock and warrantsMay 16, 2026 | investing.comTenon Medical, Inc. (NASDAQ:TNON) Q1 2026 Earnings Call TranscriptMay 13, 2026 | insidermonkey.comTenon Medical Earnings Call Highlights Rapid Growth PivotMay 13, 2026 | tipranks.comTenon(R) Medical Reports First Quarter 2026 Financial ResultsMay 12, 2026 | accessnewswire.comATenon Medical, Inc. Sets Date for First Quarter 2026 EarningsMay 1, 2026 | accessnewswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeLYRA, BTCY, TNON, and AMIX Company DescriptionsAutonomix Medical NASDAQ:AMIX$4.29 +0.06 (+1.42%) Closing price 04:00 PM EasternExtended Trading$4.36 +0.07 (+1.61%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Biotricity NASDAQ:BTCY$0.11 +0.00 (+3.96%) As of 10:48 AM EasternBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Lyra Therapeutics NASDAQ:LYRA$0.52 0.00 (0.00%) As of 07/20/2026Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Tenon Medical NASDAQ:TNON$0.20 -0.01 (-3.11%) Closing price 04:00 PM EasternExtended Trading$0.20 +0.00 (+1.23%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3M's Redemption Arc: Can Q2 Earnings Change the Narrative? Alphabet Is Planning a New AI Chip. Here's Why It Matters Ahead of Earnings 3 Photonics Companies Making Quantum Tech Possible Confidence Is Back, But Earnings Show the Consumer Is Being Picky Industrial and Utility Giants Boost Dividends as Data Center Tailwinds Build IREN’s $2.8 Billion AI Contract Haul Changes the Stock’s Story AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 2 ETFs to Access the World's Best-Performing Stock Markets In 2026 Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
